Pharmaceuticals, Biotechnology and Life Sciences
INDIANAPOLIS–(BUSINESS WIRE)–Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use of an experimental drug treatment in conjunction with a surgical procedure that treats the back…
Adoption of additional technology solutions demonstrates commitment to patients with cancer and other serious diseases
NEW YORK–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company and the global leader in creating end-to-end solutions to support t…
INDIANAPOLIS–(BUSINESS WIRE)–Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use of an experimental drug treatment in conjunction with a surgical procedure that treats the back…
Adoption of additional technology solutions demonstrates commitment to patients with cancer and other serious diseases
NEW YORK–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company and the global leader in creating end-to-end solutions to support t…
Adoption of additional technology solutions demonstrates commitment to patients with cancer and other serious diseases
NEW YORK–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company and the global leader in creating end-to-end solutions to support t…
CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc. (NASDAQ: IBRX) today announced it has begun trading as a large cap company with approximately 398 million fully diluted shares outstanding following its merger with NantKwest. The combined company…
New Data Shows 96% Are Still Managing Revenue Tasks With Spreadsheets, and 71% of Executives Believe Their Industries Could Do a Better Job Optimizing Revenue Activities
SAN MATEO, Calif.–(BUSINESS WIRE)–#modeln–Model N, Inc. (NYSE: MODN), the lea…
$2 Million SBIR Grant to Further Develop Lead Drug Compound for SARS-CoV-2 Virus and Inform Additional Applications
PITTSBURGH–(BUSINESS WIRE)–#biotech–CytoAgents, a clinical stage biotechnology company focused on the development of innovative phar…
$2 Million SBIR Grant to Further Develop Lead Drug Compound for SARS-CoV-2 Virus and Inform Additional Applications
PITTSBURGH–(BUSINESS WIRE)–#biotech–CytoAgents, a clinical stage biotechnology company focused on the development of innovative phar…
$2 Million SBIR Grant to Further Develop Lead Drug Compound for SARS-CoV-2 Virus and Inform Additional Applications
PITTSBURGH–(BUSINESS WIRE)–#biotech–CytoAgents, a clinical stage biotechnology company focused on the development of innovative phar…